MaxsMaking Inc.
MAMKMaxsMaking Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk.
The price is between stages. Underneath, the last four quarters read improving. What settles it: the next one or two quarters of delivery.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
MaxsMaking Inc. trades at $13.0, between stages. It sits at 100% of a 52-week range of $2 to $13. On relative strength it has no relative-strength read yet.
Today the stock is between stages. At $13.0 it trades near its long-run average and sits at 100% of its 52-week range ($2–$13).
Against the market, two honest reads. Cumulative: over the last 4 months the stock moved +286% while the S&P 500 moved +8% — ahead of the index over the full window. Recent form: no trailing-13-week read yet — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation P/E is the price of $1 of annual profit: how many dollars the market pays for each dollar the company earns in a year.
MaxsMaking Inc. trades at 1,06,675.7× P/E, against too little history to rank. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/E of 1,06,675.7× is against too little history to rank. This is a comparison against the stock's own history — not a claim about what it is worth.
Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.
Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
MaxsMaking Inc. reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.
Why it matters: with too little history, an honest page says so instead of guessing a trajectory.
One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.
Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +50.0% | +0.0% | — | — |
4-Factor Sector Score
44.9/100 — rank 19 of 20 in Conglomerates · 18% evidence confidence · provisional, ranked below fully-evidenced peers
MaxsMaking Inc. scores 44.9 out of 100 against the 20 companies it is compared with in Conglomerates, ranking 19. Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral.
The four contributions add to the total exactly: 16.3 + 9 + 9.6 + 10 = 44.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.
Revenue Revenue is the top line: everything the company billed its customers in the period.
MaxsMaking Inc. reported $0.0 B of revenue in the Oct 25 quarter, +100.0% year on year. Over 3 years it has compounded at 0.0% a year. The last full year, FY25, came in at $0.0 B. The last four reported quarters add to $0.1 B.
FY25 revenue came in at $0.0 B (+50.0% on the year), capping 3 years at 0.0% compound. The latest quarter (Oct 25) printed $0.0 B, +100.0% year on year.
Pace check: the last four quarters averaged +12.5% growth against the decade's 0.0% — the current year is running faster than its own long-run rate.
Operating margin Operating margin is what is left of every $100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.
MaxsMaking Inc.'s operating margin is 0.0% in the Oct 25 quarter, +0.0 percentage points against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 0.0% to 0.0%. The current quarter sits inside that band.
The latest quarter's operating margin is 0.0%, +0.0 pp against the same quarter a year ago. Across 4 fiscal years the operating margin has ranged 0.0%–0.0%.
Why the margin moved: operating margin went +0.0 pp year on year while gross margin went +0.0 pp — the gain came mostly from the gross line: input costs and pricing.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
MaxsMaking Inc. earned $0.0 B of net profit in the Oct 25 quarter. Full-year FY25 profit was $0.0 B. That is 0.0% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Oct 25 profit was $0.0 B, null year on year. On the full year, FY25 printed $0.0 B (null).
Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.
MaxsMaking Inc.'s cash-flow history is too thin to judge how much reported profit converts into cash. In FY25 that was $−0.0 B of operating cash against $0.0 B of profit. After $0.0 B of capital spending, $−0.0 B was left as free cash. Cash resolution here is annual, because quarterly cash statements are not published.
FY25: operating cash of $−0.0 B against reported profit of $0.0 B, leaving free cash of $−0.0 B after $0.0 B of capital spending.
Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.
Router verdict: the visible cash user is investment — the next section checks what the spending is buying.
Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).
MaxsMaking Inc. does not report the debtor, inventory and payable day-counts a cash cycle is built from, so this section reads the investment side instead. Capital spending ran $0.0 B over the last 3 years. Averaged over those years that is 0.0% of FY25 revenue a year.
Working-capital day-counts are not in our numbers for this stock, so this section reads the investment side — where the cash is being put to work.
On the investment side: capital spending of $0.0 B over the last 3 fiscal years.
The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.
Return on equity Return on equity (ROE) is the profit the business earns on its shareholders’ money. With the full capital-employed split not in our numbers, ROE is the cleanest long ladder we can draw here.
MaxsMaking Inc. earns a ROE of 0% in FY25. That is up from a trough of 0% in FY23. A return-on-invested-capital spread against the cost of capital is not computable from what is held here. The wiring behind it is 0.0% net margin on 1.50× asset turns.
FY25 ROE is 0%, recovered from a FY23 trough of 0% — the full ladder below shows the fall and the climb, undoctored.
Why the return is what it is — the wiring (FY25): 0.0% net margin × 1.50× asset turns × 2.00× balance-sheet leverage ≈ 0.0% on equity. Margin does its share; leverage is a meaningful part of the equation.
Dividend
MaxsMaking Inc. pays no dividend. Across the last 6 reported quarters it has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings rather than distribute them, which makes the cash-flow and reinvestment sections the place that cash shows up.
MaxsMaking Inc. does not currently pay a dividend. Across the last 6 reported quarters the company has declared no dividend per share, so there is no payout history to chart and no yield to quote. Companies at this stage typically reinvest earnings instead of distributing them.
Debt Debt-to-equity says how much of the business is funded by borrowings; interest cover says how many times operating profit pays the interest bill. Low and high, respectively, is the safe corner.
Debt-to-equity is 0.34 at the latest reading — modestly levered; a full borrowings history is not in our numbers.
We hold only the latest reading here: a debt-to-equity of 0.34 — a modest level of leverage behind the returns above. A year-by-year borrowings ladder is not in our numbers for this stock, so we say that rather than draw a chart we cannot support.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for MaxsMaking Inc., so this section names the gap rather than filling it. At typical trading volumes those positions would take about 0.2 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
MaxsMaking Inc.: the Z-score reads 5.47. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.
Why it matters: a Z-score of 5.47 sits well clear of the distress zone — the balance sheet is not the risk here.
The safety line in one sentence: the Z-score reads 5.47.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Deluxe CorporationDLX | 65.7/100Favorable setup75% evidence | ASLEEP | 24.6/35 Revenue 0.5% · PAT 85.7% · OPM change 4.3 pp 83% evidence | 13.9/25 ROCE 3.3% · OPM 13.3% 76% evidence | 15.8/20 P/E 12.1× · PEG 0.23 65% evidence | 11.4/20 RS sector -5.3% · RS bench 2.6% · 1Y 41%0 of 12 weeks ahead 70% evidence |
| Exact sum: 24.6 + 13.9 + 15.8 + 11.4 = 65.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2Honeywell International Inc.HON | 61.4/100Thin evidence · provisional58% evidence | TURNING | 19.7/35 Revenue — · PAT — · OPM change -5.6 pp 45% evidence | 18.4/25 ROCE 14.2% · OPM 16.2% 76% evidence | 11.5/20 P/E 8.3× · PEG — 15% evidence | 11.8/20 RS sector -9.2% · RS bench -0.8% · 1Y 16.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 18.4 + 11.5 + 11.8 = 61.4 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 3Falcon's Beyond Global, Inc.FBYD | 57.6/100Thin evidence · provisional58% evidence | FADING | 26.1/35 Revenue 100% · PAT -22.2% · OPM change 491.8 pp 62% evidence | 18.6/25 ROCE 29.8% · OPM 120.7% 76% evidence | 9.4/20 P/E 67.1× · PEG — 15% evidence | 3.5/20 RS sector -32.3% · RS bench -26.4% · 1Y 38.9%8 of 12 weeks ahead 70% evidence |
| Exact sum: 26.1 + 18.6 + 9.4 + 3.5 = 57.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 43M CompanyMMM | 56.7/100Thin evidence · provisional58% evidence | TURNING | 18.8/35 Revenue — · PAT — · OPM change 2.3 pp 45% evidence | 15.0/25 ROCE 3.7% · OPM 23.2% 76% evidence | 9.9/20 P/E 28.8× · PEG — 15% evidence | 13.0/20 RS sector -6.9% · RS bench 2.4% · 1Y 18.4%3 of 12 weeks ahead 100% evidence |
| Exact sum: 18.8 + 15 + 9.9 + 13 = 56.7 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 5Pampa Energía S.A.PAM | 55.9/100Mixed-positive evidence81% evidence | TURNING | 18.1/35 Revenue 14.7% · PAT -12.7% · OPM change 1.9 pp 83% evidence | 14.9/25 ROCE 3.2% · OPM 31.1% 76% evidence | 15.0/20 P/E 11.2× · PEG 0.26 65% evidence | 7.9/20 RS sector -12.6% · RS bench -4.9% · 1Y 13.5%1 of 12 weeks ahead 100% evidence |
| Exact sum: 18.1 + 14.9 + 15 + 7.9 = 55.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Valmont Industries, Inc.VMI | 55.8/100Thin evidence · provisional58% evidence | FADING | 22.0/35 Revenue — · PAT — · OPM change 1.9 pp 45% evidence | 14.8/25 ROCE 6.3% · OPM 15.1% 76% evidence | 10.3/20 P/E 22.1× · PEG — 15% evidence | 8.7/20 RS sector -6.3% · RS bench 1.8% · 1Y 36.7%7 of 12 weeks ahead 100% evidence |
| Exact sum: 22 + 14.8 + 10.3 + 8.7 = 55.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 7RCM Technologies, Inc.RCMT | 52.6/100Thin evidence · provisional52% evidence | ASLEEP | 12.0/35 Revenue — · PAT — · OPM change -92.8 pp 45% evidence | 14.9/25 ROCE 7.9% · OPM 7.2% 76% evidence | 11.3/20 P/E 9.1× · PEG — 15% evidence | 14.4/20 RS sector -0.1% · RS bench 9.6% · 1Y 26.4%6 of 12 weeks ahead 70% evidence |
| Exact sum: 12 + 14.9 + 11.3 + 14.4 = 52.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 8NN, Inc.NNBR | 47.6/100Thin evidence · provisional55% evidence | LEADER | 17.2/35 Revenue -3.3% · PAT — · OPM change 3.1 pp 62% evidence | 3.4/25 ROCE -1.1% · OPM -3.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 17.0/20 RS sector 53.9% · RS bench 67.3% · 1Y 81.6%12 of 12 weeks ahead 70% evidence |
| Exact sum: 17.2 + 3.4 + 10 + 17 = 47.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 9Otter Tail CorporationOTTR | 47.5/100Mixed-negative evidence81% evidence | TURNING | 12.0/35 Revenue -0.5% · PAT -4.8% · OPM change -0.3 pp 83% evidence | 14.5/25 ROCE 2.4% · OPM 24.6% 76% evidence | 12.2/20 P/E 13.2× · PEG 1.17 65% evidence | 8.8/20 RS sector -11.1% · RS bench -2.7% · 1Y 16.4%0 of 12 weeks ahead 100% evidence |
| Exact sum: 12 + 14.5 + 12.2 + 8.8 = 47.5 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 10Mammoth Energy Services, Inc.TUSK | 44.5/100Thin evidence · provisional58% evidence | TURNING | 16.0/35 Revenue -52.1% · PAT — · OPM change 6.1 pp 62% evidence | 5.0/25 ROCE -0.3% · OPM -3.9% 76% evidence | 10.4/20 P/E 18.5× · PEG — 15% evidence | 13.1/20 RS sector -2.7% · RS bench 5.7% · 1Y 21.8%8 of 12 weeks ahead 70% evidence |
| Exact sum: 16 + 5 + 10.4 + 13.1 = 44.5 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 11Seaboard CorporationSEB | 44.1/100Thin evidence · provisional58% evidence | ASLEEP | 19.7/35 Revenue — · PAT — · OPM change 1.9 pp 45% evidence | 10.7/25 ROCE 1.5% · OPM 4% 76% evidence | 11.1/20 P/E 9.7× · PEG — 15% evidence | 2.6/20 RS sector -20.2% · RS bench -13.7% · 1Y 24.6%0 of 12 weeks ahead 100% evidence |
| Exact sum: 19.7 + 10.7 + 11.1 + 2.6 = 44.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 12Compass DiversifiedCODI | 43.7/100Mixed-negative evidence64% evidence | ASLEEP | 13.3/35 Revenue 0.9% · PAT — · OPM change -1.3 pp 62% evidence | 7.2/25 ROCE -0.1% · OPM -0.5% 76% evidence | 9.7/20 P/E 32.1× · PEG — 15% evidence | 13.5/20 RS sector 16.1% · RS bench 25.4% · 1Y 63.9%7 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 7.2 + 9.7 + 13.5 = 43.7 · Decision use: Price leads the evidence: RS versus the benchmark is 25.4%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 13Tejon Ranch Co.TRC | 41.1/100Mixed-negative evidence68% evidence | ASLEEP | 22.5/35 Revenue 18.6% · PAT 0% · OPM change 38.8 pp 62% evidence | 6.3/25 ROCE -0.2% · OPM -11.9% 76% evidence | 7.8/20 P/E 269.1× · PEG 1.66 65% evidence | 4.5/20 RS sector -21.2% · RS bench -14% · 1Y -1.9%0 of 12 weeks ahead 70% evidence |
| Exact sum: 22.5 + 6.3 + 7.8 + 4.5 = 41.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 14Brookfield Business CorporationBBUC | 37.8/100Thin evidence · provisional58% evidence | ASLEEP | 13.3/35 Revenue — · PAT — · OPM change 0.4 pp 45% evidence | 11.3/25 ROCE 2.6% · OPM 15.8% 76% evidence | 9.2/20 P/E 80.8× · PEG — 15% evidence | 4.0/20 RS sector -21.9% · RS bench -14.4% · 1Y 25.2%0 of 12 weeks ahead 100% evidence |
| Exact sum: 13.3 + 11.3 + 9.2 + 4 = 37.8 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 15Boston Omaha CorporationBOC | 36.1/100Thin evidence · provisional58% evidence | BREAKING OUT | 13.4/35 Revenue 3.6% · PAT -480% · OPM change -4.8 pp 62% evidence | 4.5/25 ROCE -0.3% · OPM -7.7% 76% evidence | 8.5/20 P/E 579.9× · PEG — 15% evidence | 9.7/20 RS sector -7.6% · RS bench 1.6% · 1Y 11%5 of 12 weeks ahead 70% evidence |
| Exact sum: 13.4 + 4.5 + 8.5 + 9.7 = 36.1 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 16TETRA Technologies, Inc.TTI | 34.0/100Adverse evidence65% evidence | ASLEEP | 9.9/35 Revenue 4% · PAT -93.2% · OPM change -3.5 pp 83% evidence | 9.7/25 ROCE 0.7% · OPM 2.3% 76% evidence | 8.9/20 P/E 170.4× · PEG — 15% evidence | 5.5/20 RS sector -14.2% · RS bench -7.8% · 1Y 121.2%4 of 12 weeks ahead 70% evidence |
| Exact sum: 9.9 + 9.7 + 8.9 + 5.5 = 34 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 17DMC Global Inc.BOOM | 31.6/100Thin evidence · provisional58% evidence | FADING | 9.6/35 Revenue -7.4% · PAT — · OPM change -7.1 pp 62% evidence | 5.1/25 ROCE -0.8% · OPM -3% 76% evidence | 10.1/20 P/E 22.5× · PEG — 15% evidence | 6.8/20 RS sector -12.6% · RS bench -3.6% · 1Y 25%6 of 12 weeks ahead 70% evidence |
| Exact sum: 9.6 + 5.1 + 10.1 + 6.8 = 31.6 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 18Matthews International CorporationMATW | 30.7/100Adverse evidence68% evidence | ASLEEP | 10.8/35 Revenue -28.9% · PAT — · OPM change -2.6 pp 62% evidence | 6.7/25 ROCE -0.2% · OPM -1.2% 76% evidence | 5.1/20 P/E 83.3× · PEG 2.48 65% evidence | 8.1/20 RS sector -10.4% · RS bench -2.1% · 1Y 19.6%0 of 12 weeks ahead 70% evidence |
| Exact sum: 10.8 + 6.7 + 5.1 + 8.1 = 30.7 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 19MaxsMaking Inc.this pageMAMK | 44.9/100Thin evidence · provisional18% evidence | 16.3/35 Revenue — · PAT — · OPM change — 9% evidence | 9.0/25 ROCE -0.3% · OPM — 46% evidence | 9.6/20 P/E 39× · PEG — 15% evidence | 10.0/20 RS sector — · RS bench — · 1Y 388.7%5 of 6 weeks ahead to 2025-11-14 0% evidence | |
| Exact sum: 16.3 + 9 + 9.6 + 10 = 44.9 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
| 20FTAI Infrastructure Inc.FIP | 40.3/100Thin evidence · provisional42% evidence | ASLEEP | 20.1/35 Revenue — · PAT — · OPM change 8.8 pp 26% evidence | 7.2/25 ROCE 0.1% · OPM 1.5% 76% evidence | 10.0/20 P/E — · PEG — 0% evidence | 3.0/20 RS sector -44% · RS bench -38.5% · 1Y -31.7%0 of 12 weeks ahead 70% evidence |
| Exact sum: 20.1 + 7.2 + 10 + 3 = 40.3 · Decision use: Fill the missing evidence before acting; the ranking is deliberately pulled toward neutral. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led S&P 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is MaxsMaking Inc.'s stock price today?
MaxsMaking Inc. trades at $13.0. The company is valued at $0.0 B. The stock sits at 100% of its 52-week range of $2–$13. — as of 5 August 2026.
What were MaxsMaking Inc.'s latest quarterly results?
MaxsMaking Inc. reported revenue of $0.0 B and net profit of $0.0 B for the Oct 25 quarter. The operating margin was 0.0%, 0.0 pp higher than a year earlier. — as of 5 August 2026.
What is MaxsMaking Inc.'s revenue?
MaxsMaking Inc. reported revenue of $0.0 B in the Oct 25 quarter, +100.0% year on year. For the full FY25 fiscal year, revenue was $0.0 B (+50.0%). Over the last 3 years revenue compounded at 0.0% a year. — as of 5 August 2026.
What is MaxsMaking Inc.'s profit?
MaxsMaking Inc. earned $0.0 B of net profit in the Oct 25 quarter. Full-year FY25 profit was $0.0 B. The operating margin ran 0.0% in the latest quarter. — as of 5 August 2026.
What is MaxsMaking Inc.'s market cap?
MaxsMaking Inc.'s market capitalisation is $0.0 B at a stock price of $13.0. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
Does MaxsMaking Inc. pay a dividend?
No — MaxsMaking Inc. has declared no dividend per share in any of its last 6 reported quarters, so there is no payout history and no yield to quote. That is a reading of the filed statements, not an estimate. — as of 5 August 2026.
How is MaxsMaking Inc. performing?
MaxsMaking Inc.'s latest readings are below. This describes what the data did, not a rating. — as of 5 August 2026.
Will MaxsMaking Inc.'s stock price go up?
This page publishes no price forecast for MaxsMaking Inc. What it measures instead: the stock price is $13.0. Direction is not something this site claims to know. — as of 5 August 2026.
Does MaxsMaking Inc. have too much debt?
It is moderate — MaxsMaking Inc.'s debt-to-equity is 0.34. A year-by-year borrowings ladder is not in our numbers for this stock, so the latest reading is the cleanest hold. Read the returns on this page with that leverage in mind — as of 5 August 2026.
What is MaxsMaking Inc.'s capex?
MaxsMaking Inc. spent $0.0 B on capital expenditure over the last 3 fiscal years, a figure derived from the change in fixed assets plus depreciation. In FY25 alone that was $0.0 B. — as of 5 August 2026.
What is MaxsMaking Inc.'s cash flow?
MaxsMaking Inc. generated $−0.0 B of operating cash flow in FY25 and $−0.0 B of free cash flow after $0.0 B of capital spending. Reported profit that year was $0.0 B, so operating cash ran behind profit. — as of 5 August 2026.
How financially safe is MaxsMaking Inc.?
On the balance sheet, the Z-score reads 5.47 — above roughly 3 is safe, below roughly 1.8 is the distress zone. That sits well clear of trouble. — as of 5 August 2026.
Where is MaxsMaking Inc. in its business cycle?
MaxsMaking Inc.'s FY25 operating margin was 0.0%, against a 4-year band of 0.0%–0.0%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 0.0%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the MaxsMaking Inc. story?
Biggest watch item: the price is not yet in a confirmed uptrend — timing risk, not thesis risk. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is MaxsMaking Inc. a stock worth studying right now?
This is not investment advice. The machine read: MaxsMaking Inc.'s three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: the next one or two quarters of delivery. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.